Revenues up 13.1% year-over-year; Continued momentum driven by organic growth, strategic partnerships, and acquisitions
The anatomage table is one of the most advanced 3D real-tissue–based anatomy visualization systems in the world
The company plans to use the funds raised from the net proceeds to repay or prepay certain loans
WHO’s global SPECS 2030 target to increase effective refractive error coverage by 40% by 2030
This agreement grants Vizient clients enhanced access to Natrelle, the broadest selection of breast implant options on the market
The collaboration is expected to facilitate access to world-class treatments and specialised care for Iraqi personnel
Collaboration matches more eligible patients, including those with rare and complex diseases, to appropriate clinical trials
This predictive technology empowers people with diabetes to take preventive action before complications arise
Pete Pharma will leverage FABRX’s extensive foundation of scientific validation to deliver a commercially viable, pharmacy-ready solution in the US
Encouraging early detection and breaking the silence around men’s health
Subscribe To Our Newsletter & Stay Updated
